Specifications include, but are not limited to: Provide one-step urine screening drug test cups with a twelve (12) panel minimum to detect marijuana, cocaine, opiates, amphetamines, Buprenorphine, Methadone, and benzodiazepines. • The urine screening drug test cups shall have a twelve (12) panel minimum with the ability to test for, Amphetamines, Benzodiazepines , Buprenorphine, Cocaine, Ecstasy, Fentanyl, Marijuana, Methamphetamine, Methadone, Morphine, Opiate, Oxycodone. • Drug screening test cups shall not require any mixing of reagents or pretreatments/special handling of urine samples. • Each cup must have an adulteration strip. • Drug screening test cups should have a shelf life of at least twelve (12) months from the date of delivery to the AOSC. • Drug screening test cups shall be capable of producing test results within five (5) minutes. • Drug screening test cups shall be FDA-510(k) cleared to market.
